Literature DB >> 24335312

Specific nucleoprotein residues affect influenza virus morphology.

Kristy M Bialas1, Kendra A Bussey, Raychel L Stone, Toru Takimoto.   

Abstract

Influenza virus strains are often pleiomorphic, a characteristic that is largely attributed to specific residues in matrix protein 1 (M1). Although the mechanism by which M1 controls virion morphology has not yet been defined, it is suggested that the M1 interaction with other viral proteins plays an important role. In this study, we rescued recombinant virus WSN-AichiM1 containing the spherical A/WSN/33 (WSN) backbone and the M1 protein from A/Aichi/2/68 (Aichi). Aichi M1 differs from WSN M1 by 7 amino acids but includes those identified to be responsible for filamentous virion formation. Interestingly, Aichi virus produced spherical virions, while WSN-AichiM1 exhibited a long filamentous morphology, as detected by immunofluorescence and electron microscopy. Additional incorporation of Aichi nucleoprotein (NP) but not the hemagglutinin (HA), neuraminidase (NA), or M2 gene to WSN-AichiM1 abrogated filamentous virion formation, suggesting that specific M1-NP interactions affect virion morphology. Further characterization of viruses containing WSN/Aichi chimeric NPs identified residues 214, 217, and 253 of Aichi NP as necessary and sufficient for the formation of spherical virions. NP residues 214 and 217 localize at the minor groove between the two opposite-polarity NP helical strands of viral ribonucleocapsids, and residue 253 also localizes near the surface of the groove. These findings indicate that NP plays a critical role in influenza virus morphology, possibly through its interaction with the M1 layer during virus budding.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24335312      PMCID: PMC3911569          DOI: 10.1128/JVI.03354-13

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  33 in total

1.  Influenza virus hemagglutinin and neuraminidase cytoplasmic tails control particle shape.

Authors:  H Jin; G P Leser; J Zhang; R A Lamb
Journal:  EMBO J       Date:  1997-03-17       Impact factor: 11.598

2.  Association of influenza virus matrix protein with ribonucleoproteins may control viral growth and morphology.

Authors:  Teresa Liu; Jacqueline Muller; Zhiping Ye
Journal:  Virology       Date:  2002-12-05       Impact factor: 3.616

3.  Transmembrane domain of influenza virus neuraminidase, a type II protein, possesses an apical sorting signal in polarized MDCK cells.

Authors:  A Kundu; R T Avalos; C M Sanderson; D P Nayak
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

4.  The structure of native influenza virion ribonucleoproteins.

Authors:  Rocío Arranz; Rocío Coloma; Francisco Javier Chichón; José Javier Conesa; José L Carrascosa; José M Valpuesta; Juan Ortín; Jaime Martín-Benito
Journal:  Science       Date:  2012-11-22       Impact factor: 47.728

5.  Influenza virus assembly and lipid raft microdomains: a role for the cytoplasmic tails of the spike glycoproteins.

Authors:  J Zhang; A Pekosz; R A Lamb
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

6.  Reverse genetics studies on the filamentous morphology of influenza A virus.

Authors:  Svetlana V Bourmakina; Adolfo García-Sastre
Journal:  J Gen Virol       Date:  2003-03       Impact factor: 3.891

7.  The crystal structure of the influenza matrix protein M1 at neutral pH: M1-M1 protein interfaces can rotate in the oligomeric structures of M1.

Authors:  A Harris; F Forouhar; S Qiu; B Sha; M Luo
Journal:  Virology       Date:  2001-10-10       Impact factor: 3.616

8.  Role of transmembrane domain and cytoplasmic tail amino acid sequences of influenza a virus neuraminidase in raft association and virus budding.

Authors:  Subrata Barman; Lopa Adhikary; Alok K Chakrabarti; Carl Bernas; Yoshihiro Kawaoka; Debi P Nayak
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

9.  Organization of the influenza virus replication machinery.

Authors:  Arne Moeller; Robert N Kirchdoerfer; Clinton S Potter; Bridget Carragher; Ian A Wilson
Journal:  Science       Date:  2012-11-22       Impact factor: 47.728

10.  The M1 matrix protein controls the filamentous phenotype of influenza A virus.

Authors:  C J Elleman; W S Barclay
Journal:  Virology       Date:  2004-03-30       Impact factor: 3.616

View more
  14 in total

1.  Interaction of Human Parainfluenza Virus Type 3 Nucleoprotein with Matrix Protein Mediates Internal Viral Protein Assembly.

Authors:  Guangyuan Zhang; Yi Zhong; Yali Qin; Mingzhou Chen
Journal:  J Virol       Date:  2015-12-09       Impact factor: 5.103

2.  Selective incorporation of vRNP into influenza A virions determined by its specific interaction with M1 protein.

Authors:  Chutikarn Chaimayo; Tsuyoshi Hayashi; Andrew Underwood; Erin Hodges; Toru Takimoto
Journal:  Virology       Date:  2017-02-17       Impact factor: 3.616

3.  Nanoparticles decorated with viral antigens are more immunogenic at low surface density.

Authors:  Matthew G Brewer; Anthony DiPiazza; Joshua Acklin; Changyong Feng; Andrea J Sant; Stephen Dewhurst
Journal:  Vaccine       Date:  2017-01-03       Impact factor: 3.641

4.  Critical Role of the PA-X C-Terminal Domain of Influenza A Virus in Its Subcellular Localization and Shutoff Activity.

Authors:  Tsuyoshi Hayashi; Chutikarn Chaimayo; James McGuinness; Toru Takimoto
Journal:  J Virol       Date:  2016-07-27       Impact factor: 5.103

5.  The shape of pleomorphic virions determines resistance to cell-entry pressure.

Authors:  Tian Li; Zhenyu Li; Erin E Deans; Eva Mittler; Meisui Liu; Kartik Chandran; Tijana Ivanovic
Journal:  Nat Microbiol       Date:  2021-03-18       Impact factor: 17.745

6.  Identification of Influenza A/PR/8/34 Donor Viruses Imparting High Hemagglutinin Yields to Candidate Vaccine Viruses in Eggs.

Authors:  Adam Johnson; Li-Mei Chen; Emily Winne; Wanda Santana; Maureen G Metcalfe; Guaniri Mateu-Petit; Callie Ridenour; M Jaber Hossain; Julie Villanueva; Sherif R Zaki; Tracie L Williams; Nancy J Cox; John R Barr; Ruben O Donis
Journal:  PLoS One       Date:  2015-06-11       Impact factor: 3.240

7.  Critical assessment of influenza VLP production in Sf9 and HEK293 expression systems.

Authors:  Christine M Thompson; Emma Petiot; Alaka Mullick; Marc G Aucoin; Olivier Henry; Amine A Kamen
Journal:  BMC Biotechnol       Date:  2015-05-16       Impact factor: 2.563

8.  Filament-producing mutants of influenza A/Puerto Rico/8/1934 (H1N1) virus have higher neuraminidase activities than the spherical wild-type.

Authors:  Jill Seladi-Schulman; Patricia J Campbell; Suganthi Suppiah; John Steel; Anice C Lowen
Journal:  PLoS One       Date:  2014-11-10       Impact factor: 3.240

Review 9.  Compounds with anti-influenza activity: present and future of strategies for the optimal treatment and management of influenza. Part I: Influenza life-cycle and currently available drugs.

Authors:  R Gasparini; D Amicizia; P L Lai; N L Bragazzi; D Panatto
Journal:  J Prev Med Hyg       Date:  2014-09

Review 10.  Filamentous influenza viruses.

Authors:  Bernadeta Dadonaite; Swetha Vijayakrishnan; Ervin Fodor; David Bhella; Edward C Hutchinson
Journal:  J Gen Virol       Date:  2016-06-30       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.